Insider Selling: David Felsenthal Sells 6,437 Shares of Advisory Board Stock (ABCO)
Advisory Board (NASDAQ:ABCO) President David Felsenthal sold 6,437 shares of the stock on the open market in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $62.42, for a total value of $401,797.54. Following the sale, the president now directly owns 23,712 shares of the company’s stock, valued at approximately $1,480,103. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
A number of analysts have recently weighed in on ABCO shares. Analysts at Raymond James downgraded shares of Advisory Board from an “outperform” rating to a “market perform” rating in a research note to investors on Wednesday, November 6th. They now have a $66.00 price target on the stock. They noted that the move was a valuation call. Separately, analysts at Stifel Nicolaus raised their price target on shares of Advisory Board from $68.00 to $75.00 in a research note to investors on Tuesday, November 5th. They now have a “buy” rating on the stock. Finally, analysts at Craig Hallum initiated coverage on shares of Advisory Board in a research note to investors on Monday, October 14th. They set a “buy” rating on the stock. Two equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Advisory Board has an average rating of “Buy” and a consensus target price of $65.17.
Shares of Advisory Board (NASDAQ:ABCO) traded up 1.16% on Friday, hitting $61.76. The stock had a trading volume of 69,025 shares. Advisory Board has a 1-year low of $44.20 and a 1-year high of $70.55. The stock has a 50-day moving average of $62.3 and a 200-day moving average of $60.06. The company has a market cap of $2.226 billion and a P/E ratio of 93.92.
Advisory Board (NASDAQ:ABCO) last released its earnings data on Monday, November 4th. The company reported $0.31 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.29 by $0.02. The company had revenue of $128.30 million for the quarter, compared to the consensus estimate of $127.96 million. During the same quarter last year, the company posted $0.31 earnings per share. Advisory Board’s revenue was up 15.8% compared to the same quarter last year.
The Advisory Board Company provides best practices research and analysis, software tools, and management and advisory services to the health care and education industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.